162 related articles for article (PubMed ID: 23938462)
21. Nanoscale Tuning of VCAM-1 Determines VLA-4-Dependent Melanoma Cell Plasticity on RGD Motifs.
Amschler K; Kossmann E; Erpenbeck L; Kruss S; Schill T; Schön M; Möckel SMC; Spatz JP; Schön MP
Mol Cancer Res; 2018 Mar; 16(3):528-542. PubMed ID: 29222169
[TBL] [Abstract][Full Text] [Related]
22. The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin.
Schlesinger M; Roblek M; Ortmann K; Naggi A; Torri G; Borsig L; Bendas G
Thromb Res; 2014 May; 133(5):855-62. PubMed ID: 24636486
[TBL] [Abstract][Full Text] [Related]
23. IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.
Vidal-Vanaclocha F; Fantuzzi G; Mendoza L; Fuentes AM; Anasagasti MJ; Martín J; Carrascal T; Walsh P; Reznikov LL; Kim SH; Novick D; Rubinstein M; Dinarello CA
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):734-9. PubMed ID: 10639148
[TBL] [Abstract][Full Text] [Related]
24. Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions.
Liang S; Dong C
Am J Physiol Cell Physiol; 2008 Sep; 295(3):C701-7. PubMed ID: 18632734
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro.
Vidal-Vanaclocha F; Alvarez A; Asumendi A; Urcelay B; Tonino P; Dinarello CA
J Natl Cancer Inst; 1996 Feb; 88(3-4):198-205. PubMed ID: 8632494
[TBL] [Abstract][Full Text] [Related]
26. Binding between heparin and the integrin VLA-4.
Schlesinger M; Simonis D; Schmitz P; Fritzsche J; Bendas G
Thromb Haemost; 2009 Nov; 102(5):816-22. PubMed ID: 19888514
[TBL] [Abstract][Full Text] [Related]
27. IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumors.
Sasaki K; Pardee AD; Qu Y; Zhao X; Ueda R; Kohanbash G; Bailey LM; Okada H; Muthuswamy R; Kalinski P; Basse PH; Falo LD; Storkus WJ
J Immunother; 2009 Oct; 32(8):793-802. PubMed ID: 19752754
[TBL] [Abstract][Full Text] [Related]
28. VLA-4 (alpha(4)beta(1)) engagement defines a novel activation pathway for beta(2) integrin-dependent leukocyte adhesion involving the urokinase receptor.
May AE; Neumann FJ; Schömig A; Preissner KT
Blood; 2000 Jul; 96(2):506-13. PubMed ID: 10887112
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-α enhanced fusions between oral squamous cell carcinoma cells and endothelial cells via VCAM-1/VLA-4 pathway.
Song K; Zhu F; Zhang HZ; Shang ZJ
Exp Cell Res; 2012 Aug; 318(14):1707-15. PubMed ID: 22664325
[TBL] [Abstract][Full Text] [Related]
30. Membrane microvesicles as mediators for melanoma-fibroblasts communication: roles of the VCAM-1/VLA-4 axis and the ERK1/2 signal pathway.
Zhao XP; Wang M; Song Y; Song K; Yan TL; Wang L; Liu K; Shang ZJ
Cancer Lett; 2015 May; 360(2):125-33. PubMed ID: 25661735
[TBL] [Abstract][Full Text] [Related]
31. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
[TBL] [Abstract][Full Text] [Related]
32. Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4.
Schmitz P; Gerber U; Schütze N; Jüngel E; Blaheta R; Naggi A; Torri G; Bendas G
Thromb Haemost; 2013 Nov; 110(5):1046-54. PubMed ID: 24009013
[TBL] [Abstract][Full Text] [Related]
33. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5.
Hart R; Greaves DR
J Immunol; 2010 Sep; 185(6):3728-39. PubMed ID: 20720202
[TBL] [Abstract][Full Text] [Related]
34. Molecular imaging of very late antigen-4 (α4β1 integrin) in the premetastatic niche.
Shokeen M; Zheleznyak A; Wilson JM; Jiang M; Liu R; Ferdani R; Lam KS; Schwarz JK; Anderson CJ
J Nucl Med; 2012 May; 53(5):779-86. PubMed ID: 22496586
[TBL] [Abstract][Full Text] [Related]
35. Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis.
Weber C; Alon R; Moser B; Springer TA
J Cell Biol; 1996 Aug; 134(4):1063-73. PubMed ID: 8769427
[TBL] [Abstract][Full Text] [Related]
36. VLA-4 blockade suppresses endotoxin-induced uveitis: in vivo evidence for functional integrin up-regulation.
Hafezi-Moghadam A; Noda K; Almulki L; Iliaki EF; Poulaki V; Thomas KL; Nakazawa T; Hisatomi T; Miller JW; Gragoudas ES
FASEB J; 2007 Feb; 21(2):464-74. PubMed ID: 17202250
[TBL] [Abstract][Full Text] [Related]
37. Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1alpha and MIP-1beta production.
Abe M; Hiura K; Ozaki S; Kido S; Matsumoto T
J Bone Miner Metab; 2009; 27(1):16-23. PubMed ID: 19057841
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins.
Mortarini R; Anichini A; Parmiani G
Int J Cancer; 1991 Feb; 47(4):551-9. PubMed ID: 1995484
[TBL] [Abstract][Full Text] [Related]
39. The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives.
Schlesinger M; Schmitz P; Zeisig R; Naggi A; Torri G; Casu B; Bendas G
Thromb Res; 2012 May; 129(5):603-10. PubMed ID: 22099706
[TBL] [Abstract][Full Text] [Related]
40. Endothelial cells upregulate eosinophil superoxide generation via VCAM-1 expression.
Nagata M; Sedgwick JB; Vrtis R; Busse WW
Clin Exp Allergy; 1999 Apr; 29(4):550-61. PubMed ID: 10202371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
